UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Identifying cards that offer both cash back and travel points can enhance your rewards experience. Explore your options for better benefits.
28,655 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Most investors worry about market swings and fees. The real threat hides in plain sight: a risk you aren’t thinking a...
Netflix stock has fallen from its peak, heightening focus on engagement metrics. This guide breaks down what to watch...
As healthequity (HQY) approaches 2027 earnings season, investors need a clear view of how HSAs, interest income, and ...
Meta is dialing back its grand metaverse bet. This pivot could reshape the company’s profits and the stock’s long-run...
A wave of altcoins posted double-digit gains while Bitcoin steadied. Learn which coins led the rally, why it happened...
Is Microsoft truly a value opportunity, or is the market pricing in all the worst fears? This deep-dive breaks down w...
A new wave of proposals aims to tighten how decentralized finance operates in the U.S. Senate. These clarity amendmen...
Elastic faces a pivotal quarter as it closes 2026 with a cloud-first strategy. This article breaks down what to watch...
A large fund sold about $17 million in ZoomInfo shares while the company posted slim revenue growth. This article bre...
Gold-backed GLD typically delivers a steadier path than silver-backed SLV across a decade. This guide explains why, w...
The first watch restaurant stock has cooled off after a strong earnings showing, but the story isn’t just about numbe...